← Back
Data updated: Nov 8, 2026
OP NANOPHARMA
Generics Pharmaceuticals
OP NANOPHARMA is a generic drug manufacturer with 1 FDA-approved products.
2025
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
OP NANOPHARMA's Key Drugs
OP NANOPHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
OP NANOPHARMA's Recent FDA Approvals
New NDA/BLA approvals for OP NANOPHARMA over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
OP NANOPHARMA's Therapeutic Areas
Disease areas where OP NANOPHARMA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
OP NANOPHARMA Pipeline Snapshot
Active clinical trials for OP NANOPHARMA across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2025-05-23
- Latest
- 2025-05-23
- Applications
- 1